High and low doses with increased IMT, moderate (0.15–0.4 mg/kg/day) doses with decreased IMT in children [26] and adults [27] IMT: Intima-media thickness; SLE: Systemic lupus erythematosus.
Systemic lupus erythematosus (SLE), also known as lupus, is an autoimmune disease that happens when the body’s defence system, which is supposed to help our body fight infections, turns against ...
Autoimmune disorders in children can cause symptoms often mistaken for common childhood illnesses. More precise diagnoses and ...
In a new study, people with systemic lupus erythematosus (SLE) were found to be at higher risk for developing multiple cutaneous lupus erythematosus disease (CLE, lupus skin disease) subtype diagnoses ...
Dermatomyositis and lupus may share symptoms in some cases. Here's what you need to know about these autoimmune conditions.
Background A 23-year-old white woman with a 3-year history of systemic lupus erythematosus and a 15-month history of lupus nephritis and retinal vasculitis was successfully treated with ...
EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.
Children with lupus nephritis who receive ... and cyclophosphamide for the treatment of renal involvement in systemic lupus erythematosus, according to observational data published in BMC ...
The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...
Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...
Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results